Share Name Share Symbol Market Type Share ISIN Share Description
Maxcyte (DI/S) LSE:MXCT London Ordinary Share US57777K1060 COM STK USD0.01 (DI/REG S)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 135.50p 133.00p 138.00p 135.50p 135.50p 135.50p 0.00 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 6.3 -1.0 -126.2 - 58.97

Maxcyte (DI/S) Share Discussion Threads

Showing 1 to 21 of 25 messages
Chat Pages: 1
DateSubjectAuthorDiscuss
29/11/2016
09:56
don't worry timbo it will soon drift back down again
jinky2
29/11/2016
08:56
Drifting up for no easily discernable reason, normally my AIM shares do the opposite in the absence on news. If only they were all like this one (sigh!)
timbo003
28/10/2016
07:35
>>davep4, indeed. I wish I had as much in this one as have in Cyan. I seem to have an exceptional talent for underinvesting in shares which take off like this one!
timbo003
27/10/2016
14:55
timbo003 let's hope Cyan does the same soon!
davep4
27/10/2016
07:56
This week's (unexpected) performance has to be worth an animated gif! As much as I would have liked to have attended the AGM yesterday, I think travelling over to the Maryland in the US would have been beyond the call of duty given the size of my modest holding
timbo003
14/10/2016
14:47
Thanks Banshee I hope they do better than the most recent "Best Technology" award winners, for example: * 2015 award winner: Advanced Oncotherapy (down > 45% in 12 months) * 2014 award winner: Rex Bionics (down > 85% in 24 months) * 2013 award winner: Wandisco (down > 85% in 36 months).                                                         😲
timbo003
13/10/2016
20:45
Hey guys, you have just won the Aim Technology Company of the Year award for 2016, don't all cheer at once :)
banshee
27/9/2016
10:41
Thanks oshy I see there's an updated research note here: http://equitydevelopment.co.uk/edreader/?d=%3D%3DQNwIjM
timbo003
27/9/2016
10:36
Morning, short TV interview for Maxcyte's results announced this morning hxxp://fmp-tv.co.uk/company/maxcyte-investor-videos-and-news/
oshy92
27/9/2016
06:47
Finals out today, they look okay to me, but I am not that well up on the business (yet) There is an analyst telecom today with slides available on the web site later (see below) This evening they are presenting at the Shares Magazine Investor Seminar (near Tower Hill tube) along with 3 others, so I will go along to that one, it starts at around 18.00 (see details in last post) ################################################################################ Conference call for analysts A briefing for analysts will be held at 11.00am BST on 27 September 2016 at the offices of Panmure Gordon & Co., One New Change, London, EC4M 9AF. There will be a simultaneous live conference call with Q&A and the presentation will be available on MaxCyte's website at http://www.maxcyte.com/ Dial-in details: Participant dial-in: 08006940257 International dial-in: +44 (0) 1452 555566 Participant code: 86595211 An audio replay file will be made available shortly afterwards via the Company website: http://www.maxcyte.com/
timbo003
04/9/2016
06:50
Maxcyte will be presenting at the Shares Mag investor evening on September 27th http://www.sharesmagazine.co.uk/events/event/shares-investor-evening-27-sept-16 I've already booked my place.
timbo003
13/7/2016
22:08
There's a new interview with MaxCyte CEO, Doug Doerfler on Directors talk http://www.directorstalk.com/maxcyte-inc-lonmxct/ He will be visiting London in September. so hopefully that will include an investor road show (I have a growing list of questions I want to ask).
timbo003
13/7/2016
13:43
MaxCyte Inc (LON:MXCT) Chief executive Doug Doerfler very confident over prospects for the current year. 13th July 2016 http://bit.ly/29RrHGv
dice1950
12/7/2016
09:04
Encouraging trading statement this morning. Also a new research note out with a target price of 184p/share https://www.equitydevelopment.co.uk/doc/1508.pdf
timbo003
12/7/2016
07:53
MaxCyte Right here, right now: catching the CAR-T wave 12th July 2016 http://bit.ly/29SRdhp MaxCyte is already delivering strong revenue growth, due to demand for its flow electroporation devices in drug discovery and cell therapy.
dice1950
12/7/2016
07:53
!YOUTUBEVIDEO:gMdn00lCXgA: MaxCyte Right here, right now: catching the CAR-T wave 12th July 2016 https://www.equitydevelopment.co.uk/doc/1508.pdf MaxCyte is already delivering strong revenue growth, due to demand for its flow electroporation devices in drug discovery and cell therapy. MaxCyte Scalable High Throughput Transfection http://www.maxcyte.com/
dice1950
16/5/2016
17:30
There's a new video interview on ProactiveInvestors with Doug Doerfler (MaxCyte CEO) which is well worth a look, he seems very excited about their CARMA technology platform, the first product (to showcase the technology) is effective in Mouse and should be ready for the clinic (platinum resistant ovarian cancer) in H2/2017 https://www.youtube.com/watch?v=gMdn00lCXgA
timbo003
04/5/2016
19:14
There's a useful article over on Proactiveinvestors (dated May 2nd) which explains why Maxcyte (a US based company) went for an AIM IPO rather than a Nasdaq IPO. http://www.proactiveinvestors.co.uk/companies/news/125434/maxcyte-s-hybrid-model-will-appeal-to-uk-investors-125434.html
timbo003
04/4/2016
08:42
Thanks oshy, that was very helpful.
timbo003
04/4/2016
08:19
Morning, Short TV clip on MaxCyte: www.fmp-tv.co.uk/company/maxcyte-investor-videos-and-news/
oshy92
29/3/2016
17:49
That was a good start to life on Aim, up circa 10% with only three trades (total 2,407 shares traded). All a bit academic for me, as this needs to be a three year hold for the tax breaks.
timbo003
Chat Pages: 1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20161209 23:19:40